pillbase.ru

Xiidra

Active substance: lifitegrast

SOLUTION/ DROPS · LIFITEGRAST 50 mg/mL

United StatesActive

Marketing holder: Bausch & Lomb Incorporated

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Xiidra
    Lifitegrast
    EMEA/H/C/004653
    Novartis Europharm Limited
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-5236-7c52-8725-25837c5c7cc9,01a1208e-0ffb-7dca-8399-4c05a4d6a3d6,01a1208f-8c44-7dd2-a641-e9a2322f5f23;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
24208-911
Registration status
Active
Dispensing
Prescription only
Route
OPHTHALMIC
Sources
  • product · openFDA NDC · 24208-911 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 24208-911 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 24208-911 · Verified 2026-10-09 · open in source